Leading the Way in Life Science Technologies

GEN Exclusives

More »
BioMotiv - Related Content
  • Insight & Intelligence™
  • More »
  • Crossing the Valley of Death
    December 20, 2012

    BioMotiv says investments in drugs and technologies, not companies, will bring treatments to market faster.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »